| PUBCHEM ID |
88163056
|
| UNII |
UDN15LS88T
|
| Preferred Term |
L-LYSYL-L-LYSINAMIDE
|
| CAS |
134276-59-8
|
| INCHIKEY |
UELKIOISOHAUNP-UWVGGRQHSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
NCCCC[C@@H](C(N[C@@H](CCCCN)C(N)=O)=O)N
|
| Total Surface Area |
229,62
|
| Relative PSA |
0,42949
|
| TPSA |
150,25
|
| cLogS |
-1,385
|
| MW |
273,379
|
| cLogP |
-2,1417
|
| H-Acceptors |
7
|
| H-Donors |
5
|
| Ro5 violations |
0
|
| Druglikeness |
-3,7762
|
| DrugScore |
0,488707428770204
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,6329
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
2,7361
|
| Tetrahymena Pyriformis Toxicity I |
Low TPT
|
| Tetrahymena Pyriformis Toxicity II |
-0,6412
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
1,932
|
| Carcinogenicity (Three-class) |
Non-required
|
